Background and Aim
We previously reported an improvement in symptoms in Crohn’s disease following an IgG4-guided exclusion diet in an open-label study. We aimed to evaluate, in a double-blinded randomized sham-controlled setting, the efficacy of IgG4-guided diet in improving quality of life in patients with Crohn’s disease.
Consecutive patients with Crohn’s disease and a Crohn’s disease activity index (CDAI) of 80–400 attending tertiary and secondary care centers were screened. All patients had IgG4 titers tested against 16 common food types using ELISA. The true diet group excluded four food types with the highest antibody titers for 4 weeks, and the sham group excluded four foods with the lowest antibody titers. Quality of life was assessed using the Short Inflammatory Bowel Disease Questionnaire (SIBDQ) at beginning and end of the trial. Secondary outcome measures were CDAI, Harvey Bradshaw index, serum C-reactive protein, and fecal calprotectin.
One hundred and forty-five subjects were screened and 96 subjects had initial food antibody testing performed with 76 patients completing the study. Milk, beef, pork and egg were the most commonly excluded food types in the true diet group. There was a 3.05 (0.01–6.11) p < 0.05 improvement in SIBDQ and 41 (10.4–71.5) in CDAI p = 0.009.
IgG4-guided exclusion diet, as an adjunct, can improve quality of life and symptoms in patients with CD.
This is a preview of subscription content,to check access.
Access this article
Similar content being viewed by others
Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut. 2008;57:1185–1191.
D’Souza S, Levy E, Mack D, et al. Dietary patterns and risk for Crohn’s disease in children. Inflamm Bowel Dis. 2008;14:367–373.
Greenberg GR. Nutritional support in inflammatory bowel disease: current status and future directions. Scand J Gastroenterol. 1992;192:117–122.
Akobeng AK, Thomas AG. Enteral nutrition for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2007. doi:10.1002/14651858.CD005984.pub2.
Yamamoto T, Nakahigashi M, Umegae S, Matsumoto K. Enteral nutrition for the maintenance of remission in Crohn’s disease: a systematic review. Eur J Gastroenterol Hepatol. 2010;22:1–8.
Alun Jones V, Workman E, Freeman H, et al. Crohn’s disease maintenance of remission by diet. Lancet. 1985;2:177–180.
Van Den Bogaerde J, Cahill J, Emmanuel AV, et al. Gut mucosal response to food antigens in Crohn’s disease. Aliment Pharmacol Ther. 2002;16:1903–1915.
Atkinson W, Sheldon T, Shaath N, et al. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut. 2004;53:1459–1464.
Gao ZH, McAlister VC, Wright JR Jr, et al. Immunoglobulin-G subclass antidonor reactivity in transplant recipients. Liver Transplant. 2004;10:1055–1059.
Rajendran N, Kumar D. Food-specific IgG4-guided exclusion diets improve symptoms in Crohn’s disease: a pilot study. Colorectal Dis. 2011;13:1009–1013.
Langhorst J, Elsenbruch S, Koelzer J, et al. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol. 2008;103:162–169.
Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn’s relapse prevention trial. Am J Gastroenterol. 1996;91:1571–1578.
Kakodkar S, Azam JF, Mikolaitis SL, et al. The specific carbohydrate diet for inflammatory bowel disease: a case series. J Acad Nutr Diet. 2015;115:1226–1232.
Olendzki BC, Silverstein TD, Persuitte GM, et al. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr J. 2014;13:1–7.
Chan D, Kumar D, Mendall M. What is known about the mechanisms of dietary influences in Crohn’s disease? Nutrition. 2015;31:1195–1203.
Mishkin B, Yalovsky M, Mishkin S. Increased prevalence of lactose malabsorption in Crohn’s disease patients at low risk for lactose malabsorption based on ethnic origin. Am J Gastroenterol. 1997;92:1148–1153.
von Tirpitz C, Kohn C, Steinkamp M, et al. Lactose intolerance in active Crohn’s disease clinical value of duodenal lactase analysis. J Clin Gastroenterol. 2002;34:49–53.
Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106:563–573.
Teahon K, Smethurst P, Pearson M, et al. The effect of elemental diet on intestinal permeability and inflammation in Crohn’s disease. Gastroenterology. 1991;101:84–89.
Pearson M, Teahon K, Levi AJ, et al. Food intolerance and Crohn’s disease. Gut. 1993;34:783–787.
Jacobsen MB, Aukrust P, Kittang E, et al. Relation between food provocation and systemic immune activation in patients with food intolerance. Lancet. 2000;356:400–401.
Gentschew L, Ferguson LR. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res. 2012;56:524–535.
Ferguson A, Glen M, Ghosh S. Crohn’s disease: nutrition and nutritional therapy. Baillières Clin Gastroenterol. 1998;12:93–114.
Stapel SO, Asero R, Ballmer-Weber BK, et al. Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force report. Allergy. 2008;63:793–796.
Dvorak AM, Monahan RA, Osage JE, et al. Crohn’s disease: transmission electron microscopic studies: II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature. Hum Pathol. 1980;11:606–619.
Knutson L, Ahrenstedt O, Odlind B, et al. The jejunal secretion of histamine is increased in active Crohn’s disease. Gastroenterology. 1990;98:849–854.
Conflict of interest
The authors declare that there are no competing interests.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Gunasekeera, V., Mendall, M.A., Chan, D. et al. Treatment of Crohn’s Disease with an IgG4-Guided Exclusion Diet: A Randomized Controlled Trial. Dig Dis Sci 61, 1148–1157 (2016). https://doi.org/10.1007/s10620-015-3987-z